Skip to main content

Peer Review reports

From: Real-world effectiveness of vortioxetine in outpatients with major depressive disorder: functioning and dose effects

Original Submission
16 Nov 2021 Submitted Original manuscript
24 Feb 2022 Reviewed Reviewer Report
26 Apr 2022 Reviewed Reviewer Report
6 Jun 2022 Reviewed Reviewer Report - Greg Mattingly
22 Jun 2022 Author responded Author comments - Eugenia Papalexi
Resubmission - Version 2
22 Jun 2022 Submitted Manuscript version 2
24 Jun 2022 Author responded Author comments - Eugenia Papalexi
Resubmission - Version 3
24 Jun 2022 Submitted Manuscript version 3
Publishing
29 Jun 2022 Editorially accepted
12 Aug 2022 Article published 10.1186/s12888-022-04109-5

You can find further information about peer review here.

Back to article page